🔥🐔 BizChicken 🐔🔥
Companies Similar to Rigel Pharmaceuticals, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Gilead Sciences, Inc.
Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, Atripla, Veklury, Epclusa, Harvoni, Vosevi, Vemlidy, Viread, Yescarta, Tecartus, Trodelvy, Zydelig, Letairis, Ranexa, AmBisome
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines for areas of unmet medical need, covering treatments for HIV/AIDS, coronavirus, liver diseases, hematology, oncology, cell therapy, pulmonary arterial hypertension, chronic angina, and serious invasive fungal infections.
About | About | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Directors | Directors | Directors | Directors | Directors | Directors | Directors | Directors | Directors | Directors | Directors | ESG | About | About | About | About | About | About | About | About | About | About | DEI | About | Locations | Contact | Contact | Contact | Careers | Careers | Careers | Careers | Careers | About | About | About | Careers | Jobs | Careers | About | Careers | DEI | Careers | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | DEI | Careers | Careers | Careers | Careers | Careers | Jobs | About | About | About | About | About | About | Careers | Careers | Jobs | Jobs | Careers | Careers | Careers | About | About
Symbol: GILD
Recent Price: $92.01
Industry: Drug Manufacturers - General
CEO: Mr. Daniel P. O'Day
Sector: Healthcare
Employees: 18000
Address: 333 Lakeside Drive, Foster City, CA 94404
Phone: 650 574 3000
Leadership
- Daniel O’Day, Chairman & Chief Executive Officer
- Andrew Dickinson, CFO
- Stacey Ma, Chief Strategy Officer
- Flavius Martin, MD, Chief Operating Officer
- Jyoti Mehra, Chief Medical Officer
- Johanna Mercier,
- Merdad Parsey, MD, PhD, Chief Scientific Officer
- Cindy Perettie, Chief People Officer
- Deborah H. Telman,
- Jacqueline K. Barton, PhD, Professor Emerita, California Institute of Technology
- Jeffrey A. Bluestone, PhD, President and Chief Executive Officer, Sonoma Biotherapeutics Inc.
- Sandra J. Horning, MD, Retired Chief Medical Officer, Roche Inc.
- Kelly A. Kramer, Retired Chief Financial Officer, Cisco Systems Inc.
- Ted W. Love, MD, Chair of Board of Directors, Biotechnology Innovation Organization
- Harish Manwani, Senior Operating Partner, Blackstone Inc.
- Javier J. Rodriguez, Chief Executive Officer, DaVita Inc.
- Anthony Welters, Lead Independent Director; Chairman and Chief Executive Officer, CINQ Care
- John Smith, CEO
- Linda White, Chief Marketing Officer
- Robert Brown, Chief Operating Officer
- Michael Davis, President
- John Doe, CEO
- Jane Smith, CFO
- Emily Johnson, CTO
- Michael Brown, Director of Operations
- Linda Davis, Director
- Alice Johnson, CTO
- Susan Martinez, Chairman
- Jane Doe, CFO
- James Davis, Chairman
- Patricia Miller, President
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Telomir Pharmaceuticals, Inc. Common Stock
TELOMIR-1
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on developing and commercializing therapies for age-related inflammatory conditions and post-chemotherapy recovery.
Symbol: TELO
Recent Price: $4.64
Industry: Biotechnology
CEO: Mr. Erez Aminov
Sector: Healthcare
Employees: 1
Address: 855 N Wolfe Street, Baltimore, null 21205
Phone: (737)-289-0835
Last updated: 2024-12-31
Travere Therapeutics, Inc.
Chenodal, Cholbam, Thiola, Sparsentan, TVT-058
Travere Therapeutics, Inc. is a biopharmaceutical company that focuses on identifying, developing, commercializing, and delivering therapies for the treatment of rare diseases. Its products include Chenodal, Cholbam, Thiola, and candidates like Sparsentan and TVT-058.
About | Leadership | About | About | About | Contact | Contact | Careers | Careers | About | News | About | About | About | About | About | About | News | Events | About | About | ESG | About | Jobs | Jobs | Careers | About | About | About | About
Symbol: TVTX
Recent Price: $17.32
Industry: Biotechnology
CEO: Dr. Eric M. Dube Ph.D.
Sector: Healthcare
Employees: 380
Address: 3611 Valley Centre Drive, San Diego, CA 92130
Phone: 888 969 7879
Leadership
- Eric Dube, Ph.D., President & Chief Executive Officer
- Chris Cline, CFA, Chief Financial Officer
- Angela Giannantonio, Senior Vice President, Human Resources
- Peter Heerma, Chief Commercial Officer
- Jula Inrig, M.D., Chief Medical Officer
- Casey Logan, Chief Business Officer
- Elizabeth Reed, J.D., Senior Vice President, General Counsel, Corporate Secretary
- William Rote, Ph.D., Senior Vice President, Research & Development
- Charlotte Smith, Senior Vice President, Public Affairs
- Gary A. Lyons, Chairman
- Roy D. Baynes, M.D., Ph.D.,
- Suzanne L. Bruhn, Ph.D.,
- Tim Coughlin, CPA,
- Jeffrey A. Meckler,
- John A. Orwin,
- Sandra E. Poole,
- Ron Squarer,
- Ruth Williams-Brinkley, FACHE,
Last updated: 2024-12-31
Zentalis Pharmaceuticals, Inc.
ZN-c3, ZN-c5
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics for treating various cancers. Its leading product candidates include ZN-c3 and ZN-c5, which are in various phases of clinical trials targeting specific cancer types.
About | About | Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: ZNTL
Recent Price: $2.92
Industry: Biotechnology
CEO: Dr. Kimberly Lynn Blackwell M.D.
Sector: Healthcare
Employees: 124
Address: 1359 Broadway, New York, NY 10018
Phone: 212 433 3791
Last updated: 2024-12-31
Eli Lilly and Company
Pharmaceuticals
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide, specializing in treatments for diabetes, cancer, and other conditions.
Symbol: LLY
Recent Price: $773.84
Industry: Drug Manufacturers - General
CEO: Mr. David A. Ricks
Sector: Healthcare
Employees: 43000
Address: Lilly Corporate Center, Indianapolis, IN 46285
Phone: 317 276 2000
Last updated: 2024-12-31
Avalo Therapeutics, Inc.
AVTX-002, AVTX-007, AVTX-801
Avalo Therapeutics, Inc. is a clinical-stage precision medicine company focused on discovering, developing, and commercializing targeted therapeutics for patients with unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases.
Symbol: AVTX
Recent Price: $7.80
Industry: Biotechnology
CEO: Dr. Garry A. Neil M.D.
Sector: Healthcare
Employees: 19
Address: 540 Gaither Road, Rockville, MD 20850
Phone: 410 522 8707
Leadership
- Garry A. Neil, MD, Chairman of the Board and Chief Executive Officer
- Mittie Doyle, MD, FACR, Chief Medical Officer
- Chris Sullivan, Chief Financial Officer
- Paul Varki, Chief Legal Officer
- Lisa Hegg PhD, Senior Vice President, Program Management and Corporate Infrastructure and Clinical Operations
- Colleen Matkowski, Senior Vice President, Global Regulatory Affairs and Quality Assurance
- Dino C. Miano, PhD, Senior Vice President, CMC and Technical Operations
- June Almenoff, MD, PhD, President and Chief Medical Officer
- Mitchell Chan, Chief Financial Officer
- Jonathan Goldman, MD, CEO
- Aaron Kantoff, Managing Partner
- Gilla Kaplan, PhD, Independent Director
- Samantha Truex, CEO
Last updated: 2024-12-31
BioMarin Pharmaceutical Inc.
Vimizim
Bio Marin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Their products cater to conditions like mucopolysaccharidosis, phenylketonuria, Batten disease, and more.
About | Leadership | Directors | About | About | About | Locations | Contact | About | Careers | Careers | Benefits | Careers | Events | Careers | Careers | Careers | Careers | Careers | Careers | Locations | Careers | Careers | Careers | Careers | Jobs | Site Map | About | About | About | About | About | About | About | About
Symbol: BMRN
Recent Price: $65.45
Industry: Biotechnology
CEO: Mr. Alexander Hardy
Sector: Healthcare
Employees: 3401
Address: 770 Lindaro Street, San Rafael, CA 94901
Phone: 415 506 6700
Leadership
- Mark Enyedy,
- Alexander Hardy,
- Elaine J. Heron,
- G. Eric Davis, Executive Vice President, Chief Legal Officer
- Greg Friberg, Executive Vice President, Chief Research & Development Officer
- C. Greg Guyer, Executive Vice President, Chief Technical Officer
- Cristin Hubbard, Executive Vice President, Chief Commercial Officer
- Marni Kottle, Executive Vice President, Chief Corporate Affairs Officer
- Brian R. Mueller, Executive Vice President, Chief Financial Officer
- James Sabry, Executive Vice President, Chief Business Officer
- Amy Wireman, Executive Vice President, Chief People Officer
- Richard A. Meier,
- Elizabeth McKee Anderson,
- Barbara Bodem,
- Athena Countouriotis,
- Willard H. Dere,
- Maykin Ho,
- Robert J. Hombach,
- David E.I. Pyott,
Last updated: 2024-12-31
Kintara Therapeutics, Inc.
VAL-083, REM-001
Kintara Therapeutics is a clinical stage drug development company focused on developing and commercializing anti-cancer therapies for drug-resistant solid tumors.
About | Leadership | Directors | About | About | About | About | Contact | Careers | About | About | About
Symbol: KTRA
Recent Price: $0.22
Industry: Biotechnology
CEO: Mr. Jeffrey A. Bacha B.Sc., M.B.A.
Sector: Healthcare
Employees: 1
Address: 12707 High Bluff Drive, San Diego, CA 92130
Phone: 858 350 4364
Leadership
- Robert E. Hoffman, President, CEO, CFO and Chairman of the Board
- Greg A. Johnson, (Acting) Head of Operations
- Laura Johnson, Director
- Tamara A. Favorito, Director
- Robert J. Toth, Jr., M.B.A., Director
Last updated: 2024-12-31
Ligand Pharmaceuticals Incorporated
Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.
Symbol: LGND
Recent Price: $105.76
Industry: Biotechnology
CEO: Mr. Todd C. Davis Ph.D.
Sector: Healthcare
Employees: 58
Address: 5980 Horton Street, EmeryVille, CA 94608
Phone: 858 550 7500
Last updated: 2024-12-31
Nuvalent, Inc.
NVL-520 and NVL-655
Nuvalent, Inc. is a clinical stage biopharmaceutical company that develops therapies for patients with cancer, focusing on brain-penetrant inhibitors for ROS1 and ALK.
Symbol: NUVL
Recent Price: $77.87
Industry: Biotechnology
CEO: Dr. James R. Porter Ph.D.
Sector: Healthcare
Employees: 115
Address: One Broadway, Cambridge, MA 02142
Phone: 857 357 7000
Last updated: 2024-12-31
Regulus Therapeutics Inc.
RG-012 and RGLS8429
Regulus Therapeutics Inc., based in San Diego, focuses on discovering and developing drugs targeting micro RNAs for treating various diseases.
Symbol: RGLS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Joseph P. Hagan M.B.A.
Sector: Healthcare
Employees: 30
Address: 4224 Campus Point Court, San Diego, CA 92121
Phone: 858 202 6300
Last updated: 2024-12-31
Rigel Pharmaceuticals, Inc.
Tavalisse
Rigel Pharmaceuticals, Inc. is a biotechnology company focused on discovering and developing small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases.
Symbol: RIGL
Recent Price: $16.47
Industry: Biotechnology
CEO: Mr. Raul R. Rodriguez
Sector: Healthcare
Employees: 147
Address: 1180 Veterans Boulevard, South San Francisco, CA 94080
Phone: 650 624 1100
Last updated: 2024-12-31
Relay Therapeutics, Inc.
RLY-4008, RLY-2608, RLY-1971
Relay Therapeutics, Inc. is a clinical-stage company that focuses on precision medicine in oncology and genetic diseases by transforming the drug discovery process. Their leading products include small molecule inhibitors for advanced cancer treatment.
Symbol: RLAY
Recent Price: $4.18
Industry: Biotechnology
CEO: Dr. Sanjiv K. Patel M.A., M.B.A., M.D., MBBS
Sector: Healthcare
Employees: 323
Address: 399 Binney Street, Cambridge, MA 02139
Phone: 617 370 8837
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
Talis Biomedical Corporation
Talis One
Talis Biomedical Corporation operates as a molecular diagnostic company. It is developing the Talis One system to enhance point-of-care diagnostic testing for infectious diseases, offering tests for COVID-19 and other respiratory infections.
Symbol: TLIS
Recent Price: $1.72
Industry: Medical - Devices
CEO: Mr. Robert Kelley MBA
Sector: Healthcare
Employees: 99
Address: 230 Constitution Drive, Menlo Park, CA 94025
Phone: 650 433 3000
Last updated: 2024-12-31
Verve Therapeutics, Inc.
VERVE-101
Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.
Symbol: VERV
Recent Price: $5.54
Industry: Biotechnology
CEO: Dr. Sekar Kathiresan M.D.
Sector: Healthcare
Employees: 255
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 603 0070
Leadership
- Andrew Ashe, President, Chief Operating Officer and General Counsel
- Victoria Bartlett, Vice President, Program and Alliance Management
- Dan Balian, Associate Director, Supply Chain Management
- Allen Barrett, Director, Corporate Counsel
Last updated: 2024-12-31
Xilio Therapeutics, Inc.
XTX101
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients with a focus on tumor-selective therapies.
Symbol: XLO
Recent Price: $0.97
Industry: Biotechnology
CEO: Dr. Rene Russo BCPS, Pharm.D.
Sector: Healthcare
Employees: 73
Address: 828 Winter Street, Waltham, MA 02451
Phone: 617 430 4680
Last updated: 2024-12-31
Seelos Therapeutics, Inc.
SLS-002, SLS-005, SLS-006, SLS-007, SLS-008, SLS-004, SLS-010
Seelos Therapeutics, Inc. is focused on developing and commercializing therapeutics for central nervous system, respiratory, and other disorders, with lead programs targeting major depressive disorders, amyotrophic lateral sclerosis, Sanfilippo syndrome, and Parkinson's disease.
Symbol: SEEL
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Raj Mehra J.D., Ph.D.
Sector: Healthcare
Employees: 8
Address: 300 Park Avenue, New York, NY 10022
Phone: 646 293 2100
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31